All Bookmarks

Adaptive Trials in Clinical Research: Scientific and Ethical Issues to Consider

http://jama.jamanetwork.com/article.aspx?articleid=1182869

Link to JAMA paper by van der Graaf, Roes, and van Delden about using adaptive trial designs and the ethical issues that could arise from doing so.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 22 Jun 2012
 0 points

Adaptive Clinical Trials: A Partial Remedy for the Therapeutic Misconception?

http://jama.jamanetwork.com/article.aspx?articleid=1182867

Link to a paper published in JAMA by Meurer, Lewis and Berry, about using adaptive trial design to improve the likelihood of individuals benefitting from participating in trials.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 22 Jun 2012
 0 points

Online platform for Research Ethics Committees launched

http://www.edctp.org/Announcement.403+M5e1abeb9b4f.0.html?utm_source=f...

The MARC project - Mapping of research ethics review and trial regulatory capacity in sub-Saharan Africa - has launched an online review platform for Research Ethics Committees: the Research for Health and Innovation Organiser (RHInnO) platform, designed to facilitate an efficent ethical review clearance of clinical research involving human subjects.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 1 May 2012
 0 points

Reviewing Clinical Trials: a Guide for Ethics Committees

http://www.pfizer.com/files/research/research_clinical_trials/ethics_c...

An extensive document edited by Johan Karlberg and Marjorie Speers, with information for Ethics Review Committees, including an extensive introduction with information about ethics and bioethics, and how this relates to clinical research, how trials are designed and facotrs to consider when reviewing protocols.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 26 Apr 2012
 0 points

Developing New Drugs and Vaccines for Neglected Diseases of the Poor: Product Developer Landscapes

http://campaign.r20.constantcontact.com/render?llr=68y6pgdab&v=001Xj-H...

Using collected and reviewed data from the BIO Ventures for Global Health (BVGH) Global Health Primer, a new document has been compiled to shed light on the different types of organizations that are participating in product development for a broad range of neglected diseases. The results of this analysis are detailed in a new report, "Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape", available at the link above.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 2 Apr 2012
 0 points